Perkins Coie Trust CO Biogen Inc. Transaction History

Perkins Coie Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$253.3 - $285.89 $1,519 - $1,715	6 Added 37.5%	22 $5,000
Q4 2021 Jan 13, 2022	SELL	$223.92 - $287.77 $78,372 - $100,719	-350 Reduced 95.63%	16 $4,000
Q2 2021 Jul 14, 2021	BUY	$259.0 - $414.71 $4,144 - $6,635	16 Added 4.57%	366 $127,000
Q1 2018 Apr 16, 2018	SELL	$260.13 - $367.91 $13,006 - $18,395	-50 Reduced 12.5%	350 $96,000
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $112,459 - $131,876	400	400 $125,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

Stay updated on Perkins Coie Trust CO with notifications on news.